Bioorthogonal two-component drug delivery in HER2(+) breast cancer mouse models
Crossref DOI link: https://doi.org/10.1038/srep24298
Published Online: 2016-04-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hapuarachchige, Sudath
Kato, Yoshinori
Artemov, Dmitri
Text and Data Mining valid from 2016-04-12
Version of Record valid from 2016-04-12
Article History
Received: 18 January 2016
Accepted: 24 March 2016
First Online: 12 April 2016
Competing interests
: The authors declare no competing financial interests.